Holen Sie sich die Stockscreener-App
12.46
5.06%
0.60
Vorhandelsmarkt:
12.44
-0.02
-0.16%
Schlusskurs vom Vortag:
$11.86
Offen:
$11.73
24-Stunden-Volumen:
391.58K
Relative Volume:
0.48
Marktkapitalisierung:
$512.31M
Einnahmen:
$128.29M
Nettoeinkommen (Verlust:
$-30.69M
KGV:
-15.20
EPS:
-0.82
Netto-Cashflow:
$-27.17M
1W Leistung:
+8.16%
1M Leistung:
+38.44%
6M Leistung:
-18.35%
1J Leistung:
-71.13%
1-Tages-Spanne:
$11.73
$12.46
1-Wochen-Bereich:
$11.20
$12.46
52-Wochen-Spanne:
$6.32
$44.22
Rxsight Inc Stock (RXST) Company Profile
Firmenname
Rxsight Inc
Sektor
Branche
Telefon
949-521-7822
Adresse
100 COLUMBIA STREET, ALISO VIEJO
Vergleichen Sie RXST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
12.46 | 487.64M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
125.40 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.72 | 146.12B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.35 | 139.95B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.99 | 130.73B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 48.73B | 5.88B | 1.34B | 799.60M | 2.3489 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | Herabstufung | Jefferies | Buy → Hold |
| 2025-07-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-07-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-07-09 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Eingeleitet | Piper Sandler | Neutral |
| 2025-04-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-04-04 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-12-20 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-10-29 | Eingeleitet | Jefferies | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-05-07 | Bestätigt | BTIG Research | Buy |
| 2023-12-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-04-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-12-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
Alle ansehen
Rxsight Inc Aktie (RXST) Neueste Nachrichten
RxSight, Inc. $RXST Shares Purchased by Brown Capital Management LLC - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Stockholders to Connect - ACCESS Newswire
Why RxSight Inc. stock could benefit from AI revolution2025 Market Overview & Weekly Market Pulse Updates - Newser
RxSight price target raised to $10 from $9 at Morgan Stanley - MSN
How RxSight Inc. stock benefits from global expansion2025 Market Overview & Safe Entry Point Identification - Newser
Morgan Stanley Maintains RxSight (RXST) Equal-Weight Recommendation - Nasdaq
RxSight (RXST) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
RxSight (RXST) Sees Analyst Rating Update from Morgan Stanley | - GuruFocus
Investors SueWallSt as RxSight, Inc. Faces Securities Fraud Allegations - The National Law Review
RXST LAWSUIT ALERT: Levi & Korsinsky Notifies RxSight, Inc. InvestorsLead Plaintiff Deadline September 22, 2025 - The National Law Review
Grandeur Peak Global Advisors LLC Acquires 94,871 Shares of RxSight, Inc. $RXST - MarketBeat
Investors in RxSight, Inc. (RXST): Protect Your RightsContact Levi & Korsinsky Before September 22, 2025 - The National Law Review
RA CAPITAL MANAGEMENT, L.P.'s RxSight Inc(RXST) Holding History - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
What Analysts Say Is Shifting the Story for RxSight Shares - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
RxSight, Inc. (NASDAQ:RXST) institutional owners may be pleased with recent gains after 77% loss over the past year - simplywall.st
SG Americas Securities LLC Purchases 30,333 Shares of RxSight, Inc. $RXST - MarketBeat
What analysts say about RxSight Inc stockVolume Analysis Techniques & Hedge Fund-Style Analysis Now Free - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Midday Stock Roundup: RxSight up 14% - Orange County Business Journal
Will RxSight Inc. stock attract ESG investors2025 Performance Recap & Advanced Swing Trade Entry Plans - newser.com
What risks investors should watch in RxSight Inc. stockTrade Volume Summary & Detailed Earnings Play Strategies - newser.com
RxSight, Inc. to Present at the Piper Sandler Healthcare Conference - The Manila Times
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Shareholders to Connect - ACCESS Newswire
Is RxSight Inc. stock a defensive play in 2025Portfolio Update Report & Long-Term Safe Investment Plans - newser.com
Combining price and volume data for RxSight Inc.Rate Hike & Risk Managed Investment Entry Signals - newser.com
Can RxSight Inc. stock continue upward trend2025 Top Gainers & High Accuracy Buy Signal Tips - newser.com
Can RxSight Inc. stock deliver surprise earnings beatQuarterly Trade Summary & Verified Entry Point Signals - newser.com
Will a bounce in RxSight Inc. offer an exitEarnings Overview Report & Low Risk High Win Rate Picks - newser.com
Tools to monitor RxSight Inc. recovery probabilityWeekly Risk Report & Target Return Focused Picks - newser.com
OC500 2025: SHELLEY THUNEN - Orange County Business Journal
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Best data tools to analyze RxSight Inc. stock2025 Retail Activity & Technical Buy Zone Confirmations - newser.com
Is RxSight Inc. meeting your algorithmic filter criteriaMarket Trend Summary & Smart Allocation Stock Tips - newser.com
Is RxSight Inc. stock a top momentum play2025 Market Overview & Verified Swing Trading Watchlists - newser.com
Applying Elliott Wave Theory to RxSight Inc.Market Sentiment Summary & AI Optimized Trading Strategy Guides - newser.com
Finanzdaten der Rxsight Inc-Aktie (RXST)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.89%
4.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):